Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 145.67 Million | USD 180.34 Million | 2.4% | 2023 |
According to the report published by Zion Market Research, the global DNA Polymerase Market size was valued at USD 145.67 Million in 2023 and is predicted to reach USD 180.34 Million by the end of 2032. The market is expected to grow with a CAGR of 2.4% during the forecast period. The report analyzes the global DNA Polymerase Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the DNA Polymerase industry.
DNA polymerase is a kind of enzyme vital for binding nucleotides on DNA strands together. Also, it is a necessary enzyme for DNA replication. DNA polymerase is used in correcting the errors in freshly synthesized strands by a process called proofreading. During the process, the incorrect coupling is identified with the help of DNA polymerase that reverses its direction with one base pair. Incorrect segment is further eliminated by the process called excision. DNA polymerases are important for the process of translation and transcription which help in protein synthesis.
There is a vast scope for the growth of the global DNA polymerase market due to the growing incidences of genetic mutations, neurological disorders, and several other chronic diseases globally. The unique characteristic of each DNA polymerase type possesses a high potential development of reagents. As an outcome, the researchers are improving on exploring new DNA polymerase variants. The thermostable DNA polymerase finds a qualitative and important role in PCR-related methodologies in the field of molecular diagnostics. The wide utilization of DNA polymerase in point-of-care kits and molecular diagnostics is likely to influence its adoption globally. According to the World Health Organization, it is expected that there will be more than 70% of cancer cases over a decade. Furthermore, the emergence of recombinant medicines for treating life-threatening diseases is likely to create several lucrative growth opportunities in the global DNA polymerase market in the forthcoming years. However, DNA polymerase is widely used in forensic testing like DNA fingerprinting to resolve many criminal cases globally. The surging application of DNA polymerases in epigenetics research coupled with rising investments in the life science sector together will escalate the growth of the market. New protein engineering methods are adopted to extract artificial or mutant DNA polymerase. Several of such DNA polymerase is built to fit particular industry-specific purposes.
The growing awareness among people regarding the importance of DNA polymerase in DNA replication, repair hypermutation, mitochondrial replication, and PCB repair is likely to support the growth of the market during the forecast period. The ongoing technological innovations by key players are likely to positively impact the growth of the market. The high fidelity and hot-start DNA polymerase techniques are some of the innovations in the field of DNA polymerase and are expected to transform the whole industry by advancing the Sanger sequencing, next-generation sequencing, and colony screening assays which were previously inaccessible. The rising funding from key leaders to boost research activities will widen the scope of the market. Furthermore, the government initiatives to focus on adopting molecular diagnostics technology for the development of generic biologics will also support the market growth.
The global DNA polymerase market can be segmented into end-user, application, type, and region.
By end-user, the market can be segmented into diagnostic centers, academic & research institutes, pharmaceutical & biotechnology companies, and others. The diagnostic center segment holds the domination over others.
By application, the market can be segmented into next-generation sequencing applications, SNP analysis, DNA cloning, and other applications.
By type, the market can be segmented into eukaryotic and prokaryotic DNA polymerase. The prokaryotic DNA polymerase segment accounts for the largest share in the global DNA polymerase market due to its wide range of applications in diagnostic processes like PCR tests.
Report Attributes | Report Details |
---|---|
Report Name | DNA Polymerase Market |
Market Size in 2023 | USD 145.67 Million |
Market Forecast in 2032 | USD 180.34 Million |
Growth Rate | CAGR of 2.4% |
Number of Pages | 220 |
Key Companies Covered | Promega Corporation, Bioline, New England Biolabs Inc., Illumina Inc., Genescript, Takara Bio Inc., Qiagen N.V., Merck KGaA, F. Hoffmann-La Roche AG, Agilent Technologies Inc., and Thermo Fisher Scientific Inc |
Segments Covered | By end-user, By application, By type and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America accounts for the largest share in the global DNA polymerase market due to the high investments in the field of DNA polymerase by the prominent leaders in the region. Furthermore, the presence of a large number of contract manufacturing institutes and bioprocess organizations is likely to create several lucrative growth opportunities in the regional market in the forthcoming years. Also, the development of generic biologics coupled with the expiry of patent drugs further accentuates the growth of the regional market.
Asia Pacific is expected to be the fastest-growing region in the global DNA polymerase market due to the growing economy. Furthermore, the presence of big brands and prominent market leaders in the region will also accentuate the growth of the regional market. Also, a large number of organizations are collaborating with each other to boost their research capabilities and launch innovative products in the market. However, the fast proliferating forensic sector along with growing numbers of diagnostic centers in the region will also support the growth of the regional market.
Some of the significant players in the global DNA polymerase market are
By end-user
By application
By type
FrequentlyAsked Questions
There is a vast scope for the growth of the global DNA polymerase market due to the growing incidences of genetic mutations, neurological disorders, and several other chronic diseases globally. The unique characteristic of each DNA polymerase type possesses a high potential development of reagents. As an outcome, the researchers are improving on exploring new DNA polymerase variants.
Some of the significant players in the global DNA polymerase market are Promega Corporation, Bioline, New England Biolabs Inc., Illumina Inc., Genescript, Takara Bio Inc., Qiagen N.V., Merck KGaA, F. Hoffmann-La Roche AG, Agilent Technologies Inc., and Thermo Fisher Scientific Inc.
North America accounts for the largest share in the global DNA polymerase market due to the high investments in the field of DNA polymerase by the prominent leaders in the region. Furthermore, the presence of a large number of contract manufacturing institutes and bioprocess organizations is likely to create several lucrative growth opportunities in the regional market in the forthcoming years.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed